McMaster University

McMaster University

Bindi Dhesy-Thind

Bindi Dhesy-Thind

MD.(Queen's), M.Sc.(McMaster), FRCPC

Associate Professor, McMaster University
Department of Oncology — Division of Medical Oncology
Associate Chair, Education

P: 905-387-9711 Ext. 64602
F: 905-575-6326

Juravinski Cancer Centre
3rd Floor
699 Concession Street
Hamilton Ontario, L8V 5C2

Areas of Interest

Dr. Dhesy-Thind's areas of interest include breast and gastrointestinal oncology trials, translational research, investigational new drug agents, and clinical practice guidelines

Selected Publications

Pritchard,KI, Messersmith H, Elavathil L, Trudeau M, O’Malley F, Dhesy-Thind B. HER-2 and Topoisomerase II As Predictors of Response to Chemotherapy J Clin Oncol 26(5) 2008

Dhesy-Thind SK, Pritchard KI, Messersmith H, O’Malley F, Elavathil L, Trudeau M. HER2/neu in systemic therapy for women with breast cancer: a systematic review. Breast Cancer Research and Treatment published online 17 July 2007.

Grunfeld E, Dhesy-Thind SK, Levine MN for the Steering Committee for Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Follow-up after Treatment for Breast Cancer. CMAJ 172 (10); 2005.

Dhesy-Thind SK, Goffin JR, Cook RJ, Brouwers M, Reyno L, Major PP. Use of Bisphosphonates in Breast Cancer Metastatic to Bone: Compliance with Practice Guidelines. Current Oncology 9(1):7;2002.

Search for citations for Dr. Dhesy on PubMed

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0